Novel therapeutic strategy for prevention of malignant tumor recurrence after surgery: Local delivery and prolonged release of adenovirus immobilized in photocured, tissue-adhesive gelatinous matrix

Hidenobu Okino, Tatsuya Manabe, Masao Tanaka, Takehisa Matsuda

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

We have been developing a new gene delivery method using a styrenated gelatin-based tissue-adhesive matrix that allows in situ adenovirus-immobilized gel formation on living tissue and sustained virus release to permeate carcinoma tissue. Styrenated gelatin was synthesized by the condensation reaction of gelatin with 4-vinylbenzoic acid. Aqueous styrenated gelatin solution premixed with AdLacZ, adenovirus encoding β-galactosidase cDNA, and carboxylated camphorquinone (CQ) as a photoinitiator was irradiated with visible light to form a styrenated gelatin gel. The in vitro adenovirus release from the styrenated gelatin gel to a medium strongly depended not on styrenated gelatin concentration but on CQ concentration. Maximal β-galactosidase expression was observed on day 1, followed bv a rapid decrease that continued up to 1 month for a styrenated gelatin gel prepared with a low styrenated gelatin concentration and a low CQ concentration. Dose-dependent reduced expression of β-galactosidase activity with increasing CQ under photoirradiation was observed. AdLacZ-immobilized styrenated gelatin gel was formed on a hybrid tissue, which is a cell traction-induced collagenous gel entrapped with fibroblasts, and lacZ gene expression of fibroblasts in the hybrid tissue was observed for more than one month. The result of this in vitro model experiment implies that the tissue-adhesive styrenated gelatin may be applicable for the delivery of adenovirus encoding cDNA for tumor dormancy therapy into malignant tissue to prevent tumor recurrence after surgery when CDNA is properly selected.

Original languageEnglish
Pages (from-to)643-651
Number of pages9
JournalJournal of Biomedical Materials Research - Part A
Volume66
Issue number3
DOIs
Publication statusPublished - Sep 1 2003

Fingerprint

Tissue Adhesives
Gelatin
Surgery
Tumors
Adhesives
Tissue
Gels
Galactosidases
Fibroblasts
Condensation reactions
Viruses
Complementary DNA
Gene expression
Genes
Acids

All Science Journal Classification (ASJC) codes

  • Ceramics and Composites
  • Biomaterials
  • Biomedical Engineering
  • Metals and Alloys

Cite this

Novel therapeutic strategy for prevention of malignant tumor recurrence after surgery : Local delivery and prolonged release of adenovirus immobilized in photocured, tissue-adhesive gelatinous matrix. / Okino, Hidenobu; Manabe, Tatsuya; Tanaka, Masao; Matsuda, Takehisa.

In: Journal of Biomedical Materials Research - Part A, Vol. 66, No. 3, 01.09.2003, p. 643-651.

Research output: Contribution to journalArticle

@article{caaecc813ffc4c17ad0dff7aad96eea0,
title = "Novel therapeutic strategy for prevention of malignant tumor recurrence after surgery: Local delivery and prolonged release of adenovirus immobilized in photocured, tissue-adhesive gelatinous matrix",
abstract = "We have been developing a new gene delivery method using a styrenated gelatin-based tissue-adhesive matrix that allows in situ adenovirus-immobilized gel formation on living tissue and sustained virus release to permeate carcinoma tissue. Styrenated gelatin was synthesized by the condensation reaction of gelatin with 4-vinylbenzoic acid. Aqueous styrenated gelatin solution premixed with AdLacZ, adenovirus encoding β-galactosidase cDNA, and carboxylated camphorquinone (CQ) as a photoinitiator was irradiated with visible light to form a styrenated gelatin gel. The in vitro adenovirus release from the styrenated gelatin gel to a medium strongly depended not on styrenated gelatin concentration but on CQ concentration. Maximal β-galactosidase expression was observed on day 1, followed bv a rapid decrease that continued up to 1 month for a styrenated gelatin gel prepared with a low styrenated gelatin concentration and a low CQ concentration. Dose-dependent reduced expression of β-galactosidase activity with increasing CQ under photoirradiation was observed. AdLacZ-immobilized styrenated gelatin gel was formed on a hybrid tissue, which is a cell traction-induced collagenous gel entrapped with fibroblasts, and lacZ gene expression of fibroblasts in the hybrid tissue was observed for more than one month. The result of this in vitro model experiment implies that the tissue-adhesive styrenated gelatin may be applicable for the delivery of adenovirus encoding cDNA for tumor dormancy therapy into malignant tissue to prevent tumor recurrence after surgery when CDNA is properly selected.",
author = "Hidenobu Okino and Tatsuya Manabe and Masao Tanaka and Takehisa Matsuda",
year = "2003",
month = "9",
day = "1",
doi = "10.1002/jbm.a.10016",
language = "English",
volume = "66",
pages = "643--651",
journal = "Journal of Biomedical Materials Research - Part A",
issn = "1549-3296",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Novel therapeutic strategy for prevention of malignant tumor recurrence after surgery

T2 - Local delivery and prolonged release of adenovirus immobilized in photocured, tissue-adhesive gelatinous matrix

AU - Okino, Hidenobu

AU - Manabe, Tatsuya

AU - Tanaka, Masao

AU - Matsuda, Takehisa

PY - 2003/9/1

Y1 - 2003/9/1

N2 - We have been developing a new gene delivery method using a styrenated gelatin-based tissue-adhesive matrix that allows in situ adenovirus-immobilized gel formation on living tissue and sustained virus release to permeate carcinoma tissue. Styrenated gelatin was synthesized by the condensation reaction of gelatin with 4-vinylbenzoic acid. Aqueous styrenated gelatin solution premixed with AdLacZ, adenovirus encoding β-galactosidase cDNA, and carboxylated camphorquinone (CQ) as a photoinitiator was irradiated with visible light to form a styrenated gelatin gel. The in vitro adenovirus release from the styrenated gelatin gel to a medium strongly depended not on styrenated gelatin concentration but on CQ concentration. Maximal β-galactosidase expression was observed on day 1, followed bv a rapid decrease that continued up to 1 month for a styrenated gelatin gel prepared with a low styrenated gelatin concentration and a low CQ concentration. Dose-dependent reduced expression of β-galactosidase activity with increasing CQ under photoirradiation was observed. AdLacZ-immobilized styrenated gelatin gel was formed on a hybrid tissue, which is a cell traction-induced collagenous gel entrapped with fibroblasts, and lacZ gene expression of fibroblasts in the hybrid tissue was observed for more than one month. The result of this in vitro model experiment implies that the tissue-adhesive styrenated gelatin may be applicable for the delivery of adenovirus encoding cDNA for tumor dormancy therapy into malignant tissue to prevent tumor recurrence after surgery when CDNA is properly selected.

AB - We have been developing a new gene delivery method using a styrenated gelatin-based tissue-adhesive matrix that allows in situ adenovirus-immobilized gel formation on living tissue and sustained virus release to permeate carcinoma tissue. Styrenated gelatin was synthesized by the condensation reaction of gelatin with 4-vinylbenzoic acid. Aqueous styrenated gelatin solution premixed with AdLacZ, adenovirus encoding β-galactosidase cDNA, and carboxylated camphorquinone (CQ) as a photoinitiator was irradiated with visible light to form a styrenated gelatin gel. The in vitro adenovirus release from the styrenated gelatin gel to a medium strongly depended not on styrenated gelatin concentration but on CQ concentration. Maximal β-galactosidase expression was observed on day 1, followed bv a rapid decrease that continued up to 1 month for a styrenated gelatin gel prepared with a low styrenated gelatin concentration and a low CQ concentration. Dose-dependent reduced expression of β-galactosidase activity with increasing CQ under photoirradiation was observed. AdLacZ-immobilized styrenated gelatin gel was formed on a hybrid tissue, which is a cell traction-induced collagenous gel entrapped with fibroblasts, and lacZ gene expression of fibroblasts in the hybrid tissue was observed for more than one month. The result of this in vitro model experiment implies that the tissue-adhesive styrenated gelatin may be applicable for the delivery of adenovirus encoding cDNA for tumor dormancy therapy into malignant tissue to prevent tumor recurrence after surgery when CDNA is properly selected.

UR - http://www.scopus.com/inward/record.url?scp=0345168906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345168906&partnerID=8YFLogxK

U2 - 10.1002/jbm.a.10016

DO - 10.1002/jbm.a.10016

M3 - Article

C2 - 12918048

AN - SCOPUS:0345168906

VL - 66

SP - 643

EP - 651

JO - Journal of Biomedical Materials Research - Part A

JF - Journal of Biomedical Materials Research - Part A

SN - 1549-3296

IS - 3

ER -